Navigation Links
Highly specialized, minimally invasive surgery for lung cancer allows patient to go home sooner
Date:10/28/2008

Philadelphia -- Minimally-invasive surgery for lung cancer called video-assisted thoracic surgery or VATS is a relatively new procedure performed almost exclusively at academic centers. Now, a preliminary study to be presented this month at the annual CHEST meeting in Philadelphia is giving surgeons an early look at its benefits.

Conventional or open surgery for lung cancer requires a six to 10-inch incision, cutting the major muscles overlying the chest. The surgeon spreads the ribs apart with a retractor in order to view and gain access to the lung, sometimes even removing a portion of one rib. With open surgery or VATS, the surgeon removes either a section of the lung or the affected lobe.

VATS is performed with two to four small incisions (the main incision is only 2 inches long). Instead of spreading the ribs, the surgeon gains access to the lungs through a space between the ribs. By inserting a small camera, the surgeon has a magnified view of the organs on a monitor in the operating room.

"Anecdotally, we've observed similar outcomes with open surgery and VATS, but we've seen a significant advantage with VATS concerning quality of life matters," says Walter Scott, M.D., a thoracic surgeon at Fox Chase Cancer Center, one of few surgeons in the country who performs this highly-specialized surgery. "Now, we have well-analyzed comparison data that supports what we've observed in our patients."

For the study, Scott and his colleagues analyzed the records of 140 lobectomy patients who underwent VATS (74 patients) and open surgery (66 patients) for stage I non-small cell lung cancer. Five of the 74 VATS lobectomies were converted to open procedures. Operative mortality was 1/66 (1.5 percent) for open surgery and 1/74 (1.5 percent) for VATS.

"The most exciting finding is that our patients go home much sooner when they have VATS compared to open surgery," Scott says. The post-operative hospital stay was four da
'/>"/>

Contact: Karen Mallet
karen.mallet@fccc.edu
215-514-9751
Fox Chase Cancer Center
Source:Eurekalert

Page: 1 2

Related medicine news :

1. Highly-specialized, minimally-invasive surgery for lung cancer allows patient to go home sooner
2. Derma Sciences Announces 3-Year Licensing Deals for Highly Profitable Character Strip Bandages
3. CoreValve Announces That More Than 1,800 High-Risk Patients Have Been Treated with its ReValving System for Percutaneous Aortic Valve Replacement (PAVR) : Highly encouraging registry data also presented at TCT 2008
4. MD2 International Brings Highly Attentive Medicine to Chicago
5. Lincoln Park Performing Arts Center to Host Highly Acclaimed Music and Medicine Program
6. Endoscopic ultrasound highly accurate in evaluating ambiguous radiographic findings of the pancreas
7. Sigma-Aldrich and Atlas Antibodies Announce the Release of 2,000 New, Highly-Validated Prestige Antibodies
8. OptiNose presents data on highly effective migraine treatment
9. The HealthCentral Network Acquires MedTrackAlert, Extending its Ability to Reach Highly Engaged Online Health Consumers
10. Self-Monitoring of Blood Glucose Highly Effective in Diabetes Care, According to a Special Issue of Diabetes Technology and Therapeutics
11. Breast-Specific Gamma Imaging (BSGI) Found to Be Highly Sensitive for Early Stage Breast Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/3/2009)... opportunity for you to change your life - After j...u will experience a noticeable relief from the ter...sterol levels and blood pressure will return to no...will finally be freed from the health concerns tha... , Miami, FL (PRWEB) July ...
(Date:7/3/2009)...re reform details emerge, more entrepreneurs are w...nd business insurance premiums. Now, they are gett...as the Small Business Health Insurance Network to ...olis, Minn. (PRWEB) July 3, 2009 -- The health car...hich has entrepreneurs worried about how this will...
(Date:7/2/2009).../ -- Recent news reports have highlighted the impo...physicians meet high standards in their chosen are...Medical Specialties (ABMS), which coordinates and ...evelop and implement educational and professional ...physician specialists. Certification by an ABMS M...
(Date:7/2/2009)...e/ -- Dr Daniel Goldberg, a leading New Jersey oph...e the effectiveness of using 5% Betadine irrigatio...e, highly contagious and often severe form of conj... impairment due to corneal involvement. , , Oph...ster to participate in the Betadine for EKC study....
Breaking Medicine News(10 mins):Health News:Patients Suffering from Diabetes Now Have the Option to Suffer No More with Diabetic Free All Natural Medical Herbal Extracts Capsules 2Health News:Patients Suffering from Diabetes Now Have the Option to Suffer No More with Diabetic Free All Natural Medical Herbal Extracts Capsules 3Health News:Patients Suffering from Diabetes Now Have the Option to Suffer No More with Diabetic Free All Natural Medical Herbal Extracts Capsules 4Health News:Health Care Reform Details Emerge with 'Play or Pay' Requirements, Leaving Some Wondering about Small Business Owner Insurance 2Health News:Health Care Reform Details Emerge with 'Play or Pay' Requirements, Leaving Some Wondering about Small Business Owner Insurance 3Health News:Seek Out Credentials Before Choosing a Physician - Is Your Cardiologist Board Certified in Cardiovascular Disease? 2Health News:Seek Out Credentials Before Choosing a Physician - Is Your Cardiologist Board Certified in Cardiovascular Disease? 3Health News:Seek Out Credentials Before Choosing a Physician - Is Your Cardiologist Board Certified in Cardiovascular Disease? 4Health News:Ophthalmologists Invited To Participate in Betadine for EKC Treatment Study 2
...d in US to determine which of the two current medi...epam, is more effective. Childhood seizures pose...tinuous unrelenting seizures can lead to brain dam...eated. Now there are two drugs currently prescri...
...y that prohibits men who have sex with men from do...ording to the policy, which has been in effect sin...lood regardless of sexual activity, safer-sex prac...sked to fill out a questionnaire before donating, ...
...e exporters. After the furore over pet food, it is...go under the scanner. The federal government has ...othpaste till the Food and Drug Administration dec...ylene glycol, a toxic chemical commonly used in an...
...ng a unique electrical stimulation device that res...ial leg paralysis that often afflicts stroke survi...on system is available only at the Cornell Univers...e two medical centres that compose NewYork-Presbyt...
Other Medicine News:Health News:Pediatric Seizure Study Underway in US to Decide Between Diazepam and Lorazepam 2Health News:Pediatric Seizure Study Underway in US to Decide Between Diazepam and Lorazepam 3Health News:Pediatric Seizure Study Underway in US to Decide Between Diazepam and Lorazepam 4Health News:FDA Reaffirms Policy Barring MSM From Donating Blood 2Health News:US Halts Import of Chinese Toothpaste 2
(Date:6/29/2009)...RSV Burden in Outpatient Setting During First Year...arch , , GAITHERSBURG, Md., June 29 /PRNewswi...nt to pediatric research with today,s announcement...gned to assess the burden of respiratory syncytial...gestational age (GA) in outpatient settings during...
(Date:6/29/2009)... Vantia Therapeutics, an,emerging ...ecule drugs,targeting large, underserved medical ...IIa clinical trial of its lead development compoun...al VA106483 was successful in producing a,predict...s, as determined by,increased osmolality and decr...
(Date:6/26/2009)...A, Japan, June 27, 2009 Takeda Pha...nced that Takeda Global Research & Development... subsidiary received on June 26 (U.S. time) a comp...dministration (FDA) regarding the Company,s New Dr...ipeptidyl peptidase IV (DPP-4) inhibitor under inv...
(Date:6/26/2009)...al of New Anti-TNF Therapy in Three Rheumatic Dise...HORSHAM, Pa. and KENILWORTH, N.J., June 26 /PRNews... Schering-Plough Corporation (NYSE: SGP ) announ...s for Human Use (CHMP) of the European Medicines A...ng the approval of SIMPONI(TM) (golimumab) as a on...
Breaking Medicine Technology:MedImmune Funds Study to Help Gain Insights Into Full Burden of RSV Disease Among Premature Infants 2Vantia Therapeutics' Lead Candidate VA106483 Demonstrates Positive Anti-diuretic Effect in Phase IIa Trial in Nocturia 2Vantia Therapeutics' Lead Candidate VA106483 Demonstrates Positive Anti-diuretic Effect in Phase IIa Trial in Nocturia 3Takeda Receives FDA Complete Response Letter for Alogliptin, an Investigational Treatment for Type 2 Diabetes 2SIMPONI(TM) (golimumab) Receives Positive Opinion From CHMP for Once-Monthly Subcutaneous Treatment of Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis 2SIMPONI(TM) (golimumab) Receives Positive Opinion From CHMP for Once-Monthly Subcutaneous Treatment of Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis 3SIMPONI(TM) (golimumab) Receives Positive Opinion From CHMP for Once-Monthly Subcutaneous Treatment of Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis 4SIMPONI(TM) (golimumab) Receives Positive Opinion From CHMP for Once-Monthly Subcutaneous Treatment of Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis 5SIMPONI(TM) (golimumab) Receives Positive Opinion From CHMP for Once-Monthly Subcutaneous Treatment of Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis 6SIMPONI(TM) (golimumab) Receives Positive Opinion From CHMP for Once-Monthly Subcutaneous Treatment of Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis 7SIMPONI(TM) (golimumab) Receives Positive Opinion From CHMP for Once-Monthly Subcutaneous Treatment of Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis 8SIMPONI(TM) (golimumab) Receives Positive Opinion From CHMP for Once-Monthly Subcutaneous Treatment of Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis 9SIMPONI(TM) (golimumab) Receives Positive Opinion From CHMP for Once-Monthly Subcutaneous Treatment of Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis 10CDC Recommends Shingles Vaccine for Those Over 60 19501 1CDC Recommends Shingles Vaccine for Those Over 60 19501 2CDC Recommends Shingles Vaccine for Those Over 60 19501 3Nearly 40 percent of GERD patients taking PPIs experience recurring symptoms 19499 1Nearly 40 percent of GERD patients taking PPIs experience recurring symptoms 19499 2Nearly 40 percent of GERD patients taking PPIs experience recurring symptoms 19499 3VIDEO from Medialink and Johnson 26 Johnson 3A From Molecule to Medicine 19497 1District Court Decision Affirmed in U S Lovenox 28R 29 28enoxaparin sodium 29 Patent Infringement Case 19495 1District Court Decision Affirmed in U S Lovenox 28R 29 28enoxaparin sodium 29 Patent Infringement Case 19495 2
...RE)--Apr 12, 2007 - Immunicon,Corporation (NASDAQ-...for Cancer Research (AACR) at the Los Angeles,Conv...ature,Immunicon Pharma Services(SM), the new CellC...(TM) System at booth 1604., Immunicon Pharma Servi...sting services to some of the largest pharmaceutic...
...ce the risk of cancer,returning after surgery for ...) , * Patients receiving placebo in this trial wil...issions planned for use of Glivec as,adjuvant ther...rimary tumor , * Glivec already approved as effect...or inoperable Kit-positive GIST , BASEL, Switzerla...
Other Medicine Technology:Immunicon Will Exhibit CellCapture CTC Mouse/Rat Kit and EasyCount,System for Automated Cell Counting at AACR 2Immunicon Will Exhibit CellCapture CTC Mouse/Rat Kit and EasyCount,System for Automated Cell Counting at AACR 3Immunicon Will Exhibit CellCapture CTC Mouse/Rat Kit and EasyCount,System for Automated Cell Counting at AACR 4Positive Results Prompt US National Cancer Institute to Make Glivec,Available to Patients in Post-Surgical GIST Study 2Positive Results Prompt US National Cancer Institute to Make Glivec,Available to Patients in Post-Surgical GIST Study 3Positive Results Prompt US National Cancer Institute to Make Glivec,Available to Patients in Post-Surgical GIST Study 4Positive Results Prompt US National Cancer Institute to Make Glivec,Available to Patients in Post-Surgical GIST Study 5Positive Results Prompt US National Cancer Institute to Make Glivec,Available to Patients in Post-Surgical GIST Study 6
...he Prostate Specific Antigen (total PSA) test, has...tients with prostate cancer. Of the different PSA ... the first approved for the detection of prostate ...l examination (DRE) in men aged 50 years or older....
Designed specifically for use with children ages,3 and up The patient is asked to distinguish between a "Raised E" and a non stereo target.
Test and Evaluate Random Dot Stereo Depth Perception for Both,Gross Stereopsis (2500 to 1200 sec of arc) and Fine Depth,Perception. , ,The Test Includes:, Graded Circle Test (800 to 40 sec
... only handheld non-contact tonometer with over 17 ...treamlined, quiet and now, with constant puff mon... gentle puff of air. You can prove how gentle the ... before you start. With the new soft puff they wi...
Medicine Products: